Trust Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Hold
1,617
0.02% 179
2026
Q1
$296K Hold
1,617
0.02% 186
2025
Q4
$285K Sell
1,617
-58
-3% -$9.48K 0.02% 187
2025
Q3
$235K Hold
1,675
0.02% 214
2025
Q2
$210K Hold
1,675
0.02% 221
2025
Q1
$229K Buy
1,675
+13
+0.8% +$1.86K 0.02% 204
2024
Q4
$254K Hold
1,662
0.02% 200
2024
Q3
$322K Hold
1,662
0.03% 174
2024
Q2
$385K Hold
1,662
0.03% 152
2024
Q1
$358K Hold
1,662
0.03% 155
2023
Q4
$430K Hold
1,662
0.04% 140
2023
Q3
$427K Hold
1,662
0.05% 130
2023
Q2
$473K Hold
1,662
0.05% 123
2023
Q1
$462K Sell
1,662
-4
-0.2% -$1.11K 0.05% 122
2022
Q4
$461K Hold
1,666
0.06% 121
2022
Q3
$445K Buy
1,666
+112
+7% +$23.8K 0.06% 115
2022
Q2
$317K Sell
1,554
-15
-1% -$3.07K 0.04% 144
2022
Q1
$330K Buy
1,569
+22
+1% +$4.78K 0.04% 151
2021
Q4
$371K Hold
1,547
0.05% 150
2021
Q3
$438K Buy
1,547
+95
+7% +$31.1K 0.06% 125
2021
Q2
$503K Buy
1,452
+140
+11% +$42.4K 0.07% 106
2021
Q1
$367K Buy
1,312
+221
+20% +$59.6K 0.05% 121
2020
Q4
$267K Buy
1,091
+218
+25% +$56.2K 0.04% 122
2020
Q3
$248K Buy
+873
New +$243K 0.04% 105

Other funds holding BIIB

Trust Asset Management's BIIB Position: Q2 2026 in Review

Trust Asset Management held its Biogen (BIIB) position steady in Q2 2026 at 1,617 shares worth $349K. The position accounts for 0.02% of the portfolio, ranked #179.

Trust Asset Management first reported a position in BIIB in Q3 2020 and has held it in 24 quarters since. The position peaked at $503K in Q2 2021. 196 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Trust Asset Management held 1,617 shares of Biogen worth $349K as of Q2 2026.
  • Trust Asset Management left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.02% of Trust Asset Management's portfolio in Q2 2026, its #179 holding.
  • Trust Asset Management first reported a position in Biogen in Q3 2020 and has held it in 24 quarters since.
  • Trust Asset Management's Biogen position peaked at $503K in Q2 2021.
  • 196 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Trust Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.